SEARCH

SEARCH BY CITATION

References

  • Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. 2010. A method and server for predicting damaging missense mutations. Nat Methods 7:248249.
  • Altshuler DL, Durbin RM, Abecasis GR, Bentley DR, Chakravarti A, Clark AG, Collins FS, De La Vega FM, Donnelly P, Egholm M, Flicek P, Gabriel SB, Gibbs RA, Knoppers BM, Lander ES, and many others. 2010. A map of human genome variation from population-scale sequencing. Nature 467:10611073.
  • Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, Hall KP, Evers DJ, Barnes CL, Bignell HR, Boutell JM, Bryant J, Carter RJ, Keira Cheetham R, Cox AJ, and many others. 2008. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456:5359.
  • Blankenberg D, Von Kuster G, Coraor N, Ananda G, Lazarus R, Mangan M, Nekrutenko A, Taylor J. 2010. Galaxy: A web-based genome analysis tool for experimentalists. Curr Protoc Mol Biol 19:121.
  • den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat 15:712.
  • Di Bella D, Lazzaro F, Brusco A, Plumari M, Battaglia G, Pastore A, Finardi A, Cagnoli C, Tempia F, Frontali M, Veneziano L, Sacco T, Boda E, Brussino A, Bonn F, Castellotti B, Baratta S, Mariotti C, Gellera C, Fracasso V, Magri S, Langer T, Plevani P, Di Donato S, Muzi-Falconi M, Taroni F. 2010. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet 42:313321.
  • Dick KJ, Eckhardt M, Paisan-Ruiz C, Alshehhi AA, Proukakis C, Sibtain NA, Maier H, Sharifi R, Patton MA, Bashir W, Koul R, Raeburn S, Gieselmann V, Houlden H, Crosby AH. 2010. Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). Hum Mutat 31:E1251E1260.
  • EC_Regulation_on_Orphan_Medicinal_Products. 2011. EC Regulation on Orphan Medicinal Products.
  • Eurordis. 2005. Rare diseases: Understanding this public health priority.
  • Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H, Coelho A, Diekhans M, Dreszer TR, Giardine BM, Harte RA, Hillman-Jackson J, Hsu F, Kirkup V, Kuhn RM, Learned K, Li CH, Meyer LR, Pohl A, Raney BJ, Rosenbloom KR, Smith KE, Haussler D, Kent WJ. 2011. The UCSC Genome Browser database: Update 2011. Nucleic Acids Res 39:D876D882.
  • Gahl WA, Markello TC, Toro C, Fajardo KF, Sincan M, Gill F, Carlson-Donohoe H, Gropman A, Pierson TM, Golas G, Wolfe L, Groden C, Godfrey R, Nehrebecky M, Wahl C, Landis DM, Yang S, Madeo A, Mullikin JC, Boerkoel CF, Tifft CJ, Adams D. 2011. The National Institutes of Health Undiagnosed Diseases Program: Insights into rare diseases. Genet Med 14:5159.
  • Gahl WA, Tifft CJ. 2011. The NIH Undiagnosed Diseases Program: Lessons learned. JAMA 305:19041905.
  • Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, Shah P, Zhang Y, Blankenberg D, Albert I, Taylor J, Miller W, Kent WJ, Nekrutenko A. 2005. Galaxy: A platform for interactive large-scale genome analysis. Genome Res 15:14511455.
  • Gusev A, Mandoiu II, Pasaniuc B. 2008. Highly scalable genotype phasing by entropy minimization. IEEE/ACM Trans Comput Biol Bioinform 5:252261.
  • Johnston JJ, Teer JK, Cherukuri PF, Hansen NF, Loftus SK, NIH Intramural Sequencing Center (NISC), Chong K, Mullikin JC, Biesecker LG. 2010. Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate. Am J Hum Genet 86:743748.
  • Kruer MC, Paisan-Ruiz C, Boddaert N, Yoon MY, Hama H, Gregory A, Malandrini A, Woltjer RL, Munnich A, Gobin S, Polster BJ, Palmeri S, Edvardson S, Hardy J, Houlden H, Hayflick SJ. 2010. Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol 68:611618.
  • Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. 2009. The sequence alignment/map format and SAMtools. Bioinformatics 25:20782079.
  • Marchler-Bauer A, Lu SN, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, Hurwitz DI, Jackson JD, Ke ZX, Lanczycki CJ, Lu F, Marchler GH, Mullokandov M, Omelchenko MV, Robertson CL, Song JS, Thanki N, Yamashita RA, Zhang DC, Zhang NG, Zheng CJ, Bryant SH. 2011. CDD: A conserved domain database for the functional annotation of proteins. Nucleic Acids Res 39:D225D229.
  • Moore B, Hu H, Singleton M, Reese MG, De La Vega FM, Yandell M. 2011. Global analysis of disease-related DNA sequence variation in 10 healthy individuals: Implications for whole genome-based clinical diagnostics. Genet Med 13:210217.
  • Nachman MW, Crowell SL. 2000. Estimate of the mutation rate per nucleotide in humans. Genetics 156:297304.
  • Ng PC, Henikoff S. 2006. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 7:6180.
  • Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA et al. 2010. Exome sequencing identifies the cause of a mendelian disorder. Nature Genetics 42:30U41.
  • Office of Rare Diseases Research NIoH. 2011. Rare diseases and related terms.
  • Pelak K, Shianna KV, Ge DL, Maia JM, Zhu MF, Smith JP, Cirulli ET, Fellay J, Dickson SP, Gumbs CE, Heinzen EL, Need AC, Ruzzo EK, Singh A, Campbell CR, Hong LK, Lornsen KA, McKenzie AM, Sobreira NLM, Hoover-Fong JE, Milner JD, Ottman R, Haynes BF, Goedert JJ, Goldstein DB. 2010. The characterization of twenty sequenced human genomes. PLoS Genet 6:e1001111.
  • Pierson TM, Adams D, Bonn F, Martinelli P, Cherukuri PF, Teer JK, Hansen NF, Cruz P, Mullikin J, Blakesley RW, Golas G, Kwan J, Sandler A, Fuentes Fajardo K, Markello T, Tifft C, Blackstone C, Rugarli EI, Langer T, Gahl WA, Toro C. 2011a. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a novel spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases. PLoS Genet 7:e1002325.
  • Pierson TM, Adams D, Markello T, Golas G, Yang S, Sincan M, Simeonov DR, Fuentes Fajardo K, Hansen N, Cherukuri PF, Cruz P, Teer J, Mullikin JC, Boerkoel CF, Gahl WA, Tifft C. 2011b. Exome sequencing as a diagnostic tool in a case of undiagnosed juvenile-onset GM1-gangliosidosis. Neurology
  • Pierson TM, Simeonov DR, Sincan M, Adams D, Markello T, Golas G, Hansen N, Cherukuri PF, Cruz P, Mullikin JC, Blackstone C, Tifft C, Boerkoel CF, Gahl WA. 2011c. Exome sequencing and SNP analysis detects novel compound heterozygosity in fatty acid hydroxylase-associated neurodegeneration. Eur J Hum Genet
  • Schieppati A, Henter J-I, Daina E, Aperia A. 2008. Why rare diseases are an important medical and social issue. The Lancet 371:20392041.
  • Teer JK, Bonnycastle LL, Chines PS, Hansen NF, Aoyama N, Swift AJ, Abaan HO, Albert TJ, Margulies EH, Green ED, Collins FS, Mullikin JC, Biesecker LG. 2010. Systematic comparison of three genomic enrichment methods for massively parallel DNA sequencing. Genome Res 20:14201431.
  • UCSC Genome Bioinformatics Group. UCSC Genome Browser. Bed File Format. Center for Biomolecular Science & Engineering: University of California, Santa Cruz, CA.
  • Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, Hakonarson H, Bucan M. 2007. PennCNV: An integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 17:16651674.
  • Wang K, Li MY, Hakonarson H. 2010. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38:e164.
  • Yandell M, Huff C, Hu H, Singleton M, Moore B, Xing J, Jorde LB, Reese MG. 2011. A probabilistic disease-gene finder for personal genomes. Genome Res 21:15291542.